| Literature DB >> 19893709 |
P Raghukumar1, K Raghu Ram Nair, B Saju, G Zhenia, K T Divya, V S Shaiju, V Padmanabhan.
Abstract
Orthogonal film-based treatment planning is the most commonly adopted standard practice of treatment planning for cancer of the uterine cervix using high dose rate brachytherapy (HDR). This study aims at examining the variation in rectal and bladder doses when the same set of orthogonal films was given to different observers. Five physicists were given 35 pairs of orthogonal films obtained from patients who had undergone HDR brachytherapy. They were given the same instructions and asked to plan the case assuming the tumor was centrally placed, using the treatment-planning system, PLATO BPS V13.2. A statistically significant difference was observed in the average rectal (F = 3.407, P = 0.01) and bladder (F = 3.284, P = 0.013) doses and the volumes enclosed by the 100% isodose curve (P < 0.01) obtained by each observer. These variations may be attributed to the differences in the reconstruction of applicators, the selection of source positions in ovoids and the intrauterine (IU) tube, and the differences in the selection of points especially for the rectum, from lateral radiographs. These variations in planning seen within a department can be avoided if a particular source pattern is followed in the intrauterine tube, unless a specific situation demands a change. Variations in the selection of rectal points can be ruled out if the posterior vaginal surface is clearly seen.Entities:
Keywords: High dose rate brachytherapy; interobserver variation; uterine cervix
Year: 2008 PMID: 19893709 PMCID: PMC2772047 DOI: 10.4103/0971-6203.44476
Source DB: PubMed Journal: J Med Phys ISSN: 0971-6203
Figure 1Selection of Rectal and Bladder Points in AP and LAT radiographs
Percentage of patients receiving a given bladder and rectal dose (%) of Point A dose in the plans done by the five physicists
| Bladder (%) | |||||
| ≤ 80 | 6 | 11 | 14 | 26 | 14 |
| 80–100 | 34 | 46 | 57 | 49 | 43 |
| > 100 | 60 | 43 | 29 | 25 | 43 |
| Rectum (%) | |||||
| ≤ 70 | 50 | 57 | 43 | 26 | 34 |
| 70–80 | 17 | 20 | 26 | 26 | 15 |
| 80–100 | 28 | 20 | 28 | 39 | 31 |
| > 100 | 5 | 3 | 3 | 9 | 20 |
| Mean (%) Bladder dose | 104.4 | 98.3 | 72.9 | 80.9 | 83.3 |
| Mean (%) Rectal dose | 74 | 71.4 | 72.9 | 80.9 | 83.3 |
Source dwell positions selected by each physicist for the ovoids and IU tube
| Each Ovoid | |||||
| 2 | 1 | 5 | 6 | 0 | 0 |
| 3 | 32 | 30 | 29 | 32 | 33 |
| 4 | 2 | 0 | 0 | 3 | 2 |
| IU Tube | |||||
| 5 | 35 | 30 | 15 | 0 | 2 |
| 6 | 0 | 5 | 18 | 7 | 32 |
| 7 | 0 | 0 | 2 | 28 | 1 |
Parameters of 100% isodose volume
| Dimension in cm | Physicists | ||||
|---|---|---|---|---|---|
| A | B | C | D | E | |
| Dw | 5.7 | 5.5 | 5.5 | 5.3 | 5.4 |
| Dh | 8.3 | 7.7 | 7.8 | 7.9 | 8.1 |
| Dt | 4.6 | 4.3 | 4.1 | 4.1 | 4.2 |
| Volume (cm3) | 219.6 | 185.4 | 185.1 | 172.5 | 181.7 |
Figure 2Diagram showing source positions in the applicator, 100% isodose volume passing through A1, A2 and the height (Dh), width (Dw) and thickness (Dt) of the isodose volume